{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:21:57Z","timestamp":1777008117056,"version":"3.51.4"},"reference-count":178,"publisher":"Elsevier","isbn-type":[{"value":"9780323992275","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.apcsb.2021.11.004","type":"book-chapter","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T16:11:44Z","timestamp":1647447104000},"page":"435-477","source":"Crossref","is-referenced-by-count":15,"title":["Antivenom: An immunotherapy for the treatment of snakebite envenoming in sub-Saharan Africa"],"prefix":"10.1016","member":"78","reference":[{"issue":"7","key":"10.1016\/bs.apcsb.2021.11.004_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000767","article-title":"Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria","volume":"4","author":"Abubakar","year":"2010","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"8","key":"10.1016\/bs.apcsb.2021.11.004_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008579","article-title":"An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management","volume":"14","author":"Ainsworth","year":"2020","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jprot.2017.08.016","article-title":"The medical threat of mamba envenoming in sub-Saharan Africa revealed by genus-wide analysis of venom composition, toxicity and antivenomics profiling of available antivenoms","volume":"172","author":"Ainsworth","year":"2018","journal-title":"Journal of Proteomics"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.toxicon.2012.12.022","article-title":"Long-term physicochemical and immunological stability of a liquid formulated intact ovine immunoglobulin-based antivenom","volume":"64","author":"Al-Abdulla","year":"2013","journal-title":"Toxicon"},{"issue":"1\u20132","key":"10.1016\/bs.apcsb.2021.11.004_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2013.11.001","article-title":"Single-reagent one-step procedures for the purification of ovine IgG, F (ab') 2 and fab antivenoms by caprylic acid","volume":"402","author":"Al-Abdulla","year":"2014","journal-title":"Journal of Immunological Methods"},{"issue":"9","key":"10.1016\/bs.apcsb.2021.11.004_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003896","article-title":"Antivenoms for snakebite envenoming: What is in the research pipeline?","volume":"9","author":"Alirol","year":"2015","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000603","article-title":"Snake bite in South Asia: A review","volume":"4","author":"Alirol","year":"2010","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"4","key":"10.1016\/bs.apcsb.2021.11.004_bb0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jsps.2014.04.008","article-title":"Drug safety: The concept, inception and its importance in patients' health","volume":"24","author":"Alshammari","year":"2016","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"8","key":"10.1016\/bs.apcsb.2021.11.004_bb0050","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3390\/toxins6082541","article-title":"Engineering venom's toxin-neutralizing antibody fragments and its therapeutic potential","volume":"6","author":"Alvarenga","year":"2014","journal-title":"Toxins (Basel)"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13149-012-0223-3","article-title":"\u00c9tude clinique de la tol\u00e9rance et de l'efficacit\u00e9 d'un s\u00e9rum anti-ophidien polyvalent F (ab') 2 pour l'Afrique \u00e0 Kindia, Guin\u00e9e","volume":"105","author":"Bald\u00e9","year":"2012","journal-title":"Bulletin de la Societe de Pathologie Exotique"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1678-9199-19-6","article-title":"Use of antivenoms for the treatment of envenomation by Elapidae snakes in Guinea, sub-Saharan Africa","volume":"19","author":"Bald\u00e9","year":"2013","journal-title":"Journal of Venomous Animals and Toxins Including Tropical Diseases"},{"issue":"1666","key":"10.1016\/bs.apcsb.2021.11.004_bb0070","first-page":"2443","article-title":"Coevolution of diet and prey-specific venom activity supports the role of selection in snake venom evolution","volume":"276","author":"Barlow","year":"2009","journal-title":"Proceedings of the Biological Sciences"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s40409-018-0151-1","article-title":"Delayed double reading of whole blood clotting test (WBCT) results at 20 and 30 minutes enhances diagnosis and treatment of viper evenomation","volume":"24","author":"Benjamin","year":"2018","journal-title":"Journal of Venomous Animals and Toxins Including Tropical Diseases"},{"issue":"4","key":"10.1016\/bs.apcsb.2021.11.004_bb0080","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/bp034037+","article-title":"Kinetics of whole serum and prepurified IgG digestion by pepsin for F (ab') 2 manufacture","volume":"19","author":"Boushaba","year":"2003","journal-title":"Biotechnology Progress"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1067\/mem.2001.113134","article-title":"Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline fab antivenom","volume":"37","author":"Boyer","year":"2001","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0090","series-title":"Cleavage of IgGs by proteases associated with invasive diseases: An evasion tactic against host immunity?","year":"2010"},{"issue":"6","key":"10.1016\/bs.apcsb.2021.11.004_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001670","article-title":"Consequences of neglect: Analysis of the sub-Saharan African snake antivenom market and the global context","volume":"6","author":"Brown","year":"2012","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biologicals.2004.07.001","article-title":"Assessment of the viral safety of antivenoms fractionated from equine plasma","volume":"32","author":"Burnouf","year":"2004","journal-title":"Biologicals"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/15563650.2014.974263","article-title":"Comparison of F(ab')2 versus fab antivenom for pit viper envenomation: A prospective, blinded, multicenter, randomized clinical trial","volume":"53","author":"Bush","year":"2015","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"issue":"7","key":"10.1016\/bs.apcsb.2021.11.004_bb0110","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1021\/pr0701714","article-title":"Snake venomics of Bitis species reveals large intragenus venom toxin composition variation: Application to taxonomy of congeneric taxa","volume":"6","author":"Calvete","year":"2007","journal-title":"Journal of Proteome Research"},{"issue":"12","key":"10.1016\/bs.apcsb.2021.11.004_bb0115","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.3390\/toxins6123388","article-title":"Omics meets biology: Application to the design and preclinical assessment of antivenoms","volume":"6","author":"Calvete","year":"2014","journal-title":"Toxins (Basel)"},{"issue":"6","key":"10.1016\/bs.apcsb.2021.11.004_bb0120","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.4269\/ajtmh.2010.09-0733","article-title":"Antivenomic assessment of the immunological reactivity of EchiTAb-plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa","volume":"82","author":"Calvete","year":"2010","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1016\/bs.apcsb.2021.11.004_bb0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.annemergmed.2007.09.036","article-title":"Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune fab antivenom","volume":"51","author":"Cannon","year":"2008","journal-title":"Annals of Emergency Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0130","doi-asserted-by":"crossref","first-page":"12067","DOI":"10.1038\/s41598-018-30578-4","article-title":"Snake venom extracellular vesicles (SVEVs) reveal wide molecular and functional proteome diversity","volume":"8","author":"Carregari","year":"2018","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1016\/bs.apcsb.2021.11.004_bb0135","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3390\/toxins6082471","article-title":"Immunological cross-reactivity and neutralisation of European viper venoms with the monospecific Vipera berus antivenom ViperaTAb","volume":"6","author":"Casewell","year":"2014","journal-title":"Toxins (Basel)"},{"issue":"10","key":"10.1016\/bs.apcsb.2021.11.004_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000851","article-title":"Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom","volume":"4","author":"Casewell","year":"2010","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0145","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/1471-2164-10-564","article-title":"Comparative venom gland transcriptome surveys of the saw-scaled vipers (Viperidae: Echis) reveal substantial intra-family gene diversity and novel venom transcripts","volume":"10","author":"Casewell","year":"2009","journal-title":"BMC Genomics"},{"issue":"4","key":"10.1016\/bs.apcsb.2021.11.004_bb0150","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.toxicon.2010.12.022","article-title":"Estimate of the burden of snakebites in sub-Saharan Africa: A meta-analytic approach","volume":"57","author":"Chippaux","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40409-017-0127-6","article-title":"Snakebite envenomation turns again into a neglected tropical disease!","volume":"23","author":"Chippaux","year":"2017","journal-title":"Journal of Venomous Animals and Toxins Including Tropical Diseases"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0160","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4269\/ajtmh.2007.77.538","article-title":"Clinical trial of an F (ab') 2 polyvalent equine antivenom for African snake bites in Benin","volume":"77","author":"Chippaux","year":"2007","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"7","key":"10.1016\/bs.apcsb.2021.11.004_bb0165","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.toxicon.2010.02.022","article-title":"Methodology of clinical studies dealing with the treatment of envenomation","volume":"55","author":"Chippaux","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0170","series-title":"Snake venoms\u2013Toxinology","first-page":"1","article-title":"Antivenom safety and tolerance for the strategy of snake envenomations management","author":"Chippaux","year":"2015"},{"issue":"11","key":"10.1016\/bs.apcsb.2021.11.004_bb0175","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0041-0101(91)90116-9","article-title":"Snake venom variability: Methods of study, results and interpretation","volume":"29","author":"Chippaux","year":"1991","journal-title":"Toxicon"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.583587","article-title":"Cytotoxicity of Snake venoms and Cytotoxins from two southeast Asian cobras (Naja sumatrana, Naja kaouthia): Exploration of anticancer potential, selectivity, and cell death mechanism","volume":"7","author":"Chong","year":"2020","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"12","key":"10.1016\/bs.apcsb.2021.11.004_bb0185","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3390\/toxins11120702","article-title":"Immunogenic properties of recombinant enzymes from Bothrops ammodytoides towards the generation of neutralizing antibodies against its own venom","volume":"11","author":"Clement","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0190","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.toxicon.2013.05.017","article-title":"Cytotoxic activities of [Ser(4)(9)]phospholipase a(2) from the venom of the saw-scaled vipers Echis ocellatus, Echis pyramidum leakeyi, Echis carinatus sochureki, and Echis coloratus","volume":"71","author":"Conlon","year":"2013","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.toxicon.2010.04.005","article-title":"Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology","volume":"56","author":"Cook","year":"2010","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/BA20050020","article-title":"Optimal conditions for the papain digestion of polyclonal ovine IgG for the production of biotherapeutic fab fragments","volume":"42","author":"Cresswell","year":"2005","journal-title":"Biotechnology and Applied Biochemistry"},{"issue":"4","key":"10.1016\/bs.apcsb.2021.11.004_bb0205","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.toxicon.2009.12.009","article-title":"Intra-specific variation in venom of the African puff adder (Bitis arietans): Differential expression and activity of snake venom metalloproteinases (SVMPs)","volume":"55","author":"Currier","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0210","series-title":"Clinical Toxinology in Asia Pacific and Africa","first-page":"300","article-title":"Socioeconomic aspects of snakebite in Africa and the tropics","author":"Dalhat","year":"2015"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0215","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1067\/mem.2001.113372","article-title":"Efficacy, safety, and use of snake antivenoms in the United States","volume":"37","author":"Dart","year":"2001","journal-title":"Annals of Emergency Medicine"},{"issue":"7","key":"10.1016\/bs.apcsb.2021.11.004_bb0220","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00726-018-2556-0","article-title":"Short-chain consensus alpha-neurotoxin: A synthetic 60-mer peptide with generic traits and enhanced immunogenic properties","volume":"50","author":"de la Rosa","year":"2018","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-11639-2","article-title":"Horse immunization with short-chain consensus \u03b1-neurotoxin generates antibodies against broad spectrum of elapid venomous species","volume":"10","author":"De la Rosa","year":"2019","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0230","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/bcp.12739","article-title":"Adverse reactions to snake antivenom, and their prevention and treatment","volume":"81","author":"de Silva","year":"2016","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1016\/bs.apcsb.2021.11.004_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000435","article-title":"Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: A randomised, double-blind, placebo-controlled trial","volume":"8","author":"de Silva","year":"2011","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0240","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/toxsci\/kfv140","article-title":"Determination of toxic activities in Bothrops spp. snake venoms using animal-free approaches: Correlation between in vitro versus in vivo assays","volume":"147","author":"de Souza","year":"2015","journal-title":"Toxicological Sciences"},{"issue":"5","key":"10.1016\/bs.apcsb.2021.11.004_bb0245","article-title":"Study on acute adverse drug reactions of antisnake venom in a rural tertiary care hospital","volume":"7","author":"Deshmukh","year":"2014","journal-title":"Asian Journal of Pharmaceutical and Clinical Research"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0250","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/978-94-007-6386-9_39","article-title":"Snake venom detection kit (svdk): Update on current aspects and challenges","author":"Dhananjaya","year":"2015","journal-title":"Clinical Toxinology in Asia Pacific and Africa"},{"issue":"5","key":"10.1016\/bs.apcsb.2021.11.004_bb0255","first-page":"343","article-title":"The humoral immune response induced by snake venom toxins","volume":"10","author":"Dias da Silva","year":"2011","journal-title":"Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy)"},{"issue":"17","key":"10.1016\/bs.apcsb.2021.11.004_bb0260","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1007\/s00018-009-0050-2","article-title":"Protein complexes in snake venom","volume":"66","author":"Doley","year":"2009","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0265","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-12-420119-4.00007-0","article-title":"Salting out of proteins using ammonium sulfate precipitation","volume":"541","author":"Duong-Ly","year":"2014","journal-title":"Methods in Enzymology"},{"issue":"7","key":"10.1016\/bs.apcsb.2021.11.004_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004813","article-title":"Mapping the risk of snakebite in Sri Lanka - a National Survey with geospatial analysis","volume":"10","author":"Ediriweera","year":"2016","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"2122","key":"10.1016\/bs.apcsb.2021.11.004_bb0275","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2014.13940","article-title":"Vaccine adjuvants\u2013understanding molecular mechanisms to improve vaccines","volume":"144","author":"Egli","year":"2014","journal-title":"Swiss Medical Weekly"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2478\/intox-2018-0001","article-title":"Advances in acute toxicity testing: Strengths, weaknesses and regulatory acceptance","volume":"11","author":"Erhirhie","year":"2018","journal-title":"Interdisciplinary Toxicology"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0285","first-page":"55","article-title":"Biogeography of the White-bellied carpet viper Echis leucogaster Roman, 1972 in Morocco, a study combining mitochondrial DNA data and ecological niche modeling","volume":"18","author":"Escoriza","year":"2009","journal-title":"Butll. Soc. Cat. Herp."},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0290","doi-asserted-by":"crossref","unstructured":"Ferraz, C. R., Arrahman, A., Xie, C., Casewell, N. R., Lewis, R. J., Kool, J. and C. C. F. (2019). Multifunctional toxins in Snake venoms and therapeutic implications: From pain to hemorrhage and necrosis. Frontiers in Ecology and Evolution 7:218., https:\/\/doi.org\/10.3389\/fevo.2019.00218","DOI":"10.3389\/fevo.2019.00218"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0295","series-title":"Critical care toxicology","article-title":"Asian Snakes","author":"Ghose","year":"2016"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0300","first-page":"108","article-title":"Purification, fragmentation and isotopic labelling of monoclonal antibodies","author":"Goding","year":"1986","journal-title":"Monoclonal antibodies: Principles and practice"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004325","article-title":"Development of equine IgG Antivenoms against Major Snake groups in Mozambique","volume":"10","author":"Guidolin","year":"2016","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0310","doi-asserted-by":"crossref","first-page":"17079","DOI":"10.1038\/nrdp.2017.79","article-title":"Snakebite envenoming","volume":"3","author":"Gutierrez","year":"2017","journal-title":"Nature Reviews. Disease Primers"},{"issue":"6","key":"10.1016\/bs.apcsb.2021.11.004_bb0315","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0041-0101(85)90380-0","article-title":"Neutralization of proteolytic and hemorrhagic activities of costa Rican snake venoms by a polyvalent antivenom","volume":"23","author":"Guti\u00e9rrez","year":"1985","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/bs.apcsb.2021.11.004_bb0320","first-page":"369","article-title":"Antivenoms for snakebite envenomings","volume":"10","author":"Gutierrez","year":"2011","journal-title":"Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy)"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0325","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.toxicon.2006.09.005","article-title":"Strengthening antivenom production in central and south American public laboratories: Report of a workshop","volume":"49","author":"Guti\u00e9rrez","year":"2007","journal-title":"Toxicon"},{"issue":"8","key":"10.1016\/bs.apcsb.2021.11.004_bb0330","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00003088-200342080-00002","article-title":"Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation","volume":"42","author":"Guti\u00e9rrez","year":"2003","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0335","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jprot.2014.02.021","article-title":"Immunological profile of antivenoms: Preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays","volume":"105","author":"Gutierrez","year":"2014","journal-title":"Journal of Proteomics"},{"issue":"6","key":"10.1016\/bs.apcsb.2021.11.004_bb0340","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.trstmh.2004.09.014","article-title":"Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: An alternative to the antivenom crisis in Africa","volume":"99","author":"Gutierrez","year":"2005","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0345","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.toxicon.2012.11.016","article-title":"Assessing the preclinical efficacy of antivenoms: From the lethality neutralization assay to antivenomics","volume":"69","author":"Guti\u00e9rrez","year":"2013","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/bs.apcsb.2021.11.004_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9050163","article-title":"Preclinical evaluation of the efficacy of Antivenoms for snakebite envenoming: State-of-the-art and challenges ahead","volume":"9","author":"Gutierrez","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0355","series-title":"Clinical Toxinology in Asia Pacific and Africa","first-page":"275","article-title":"Venomous snakes and Snake envenomation in Nigeria","author":"Habib","year":"2015"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0360","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.inhe.2010.08.001","article-title":"Factors affecting snakebite mortality in North-Eastern Nigeria","volume":"3","author":"Habib","year":"2011","journal-title":"International Health"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0365","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.toxicon.2013.01.002","article-title":"Antivenom therapy of carpet viper (Echis ocellatus) envenoming: Effectiveness and strategies for delivery in West Africa","volume":"69","author":"Habib","year":"2013","journal-title":"Toxicon"},{"issue":"9","key":"10.1016\/bs.apcsb.2021.11.004_bb0370","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1365-3156.2008.02122.x","article-title":"Envenoming after carpet viper (Echis ocellatus) bite during pregnancy: Timely use of effective antivenom improves maternal and foetal outcomes","volume":"13","author":"Habib","year":"2008","journal-title":"Tropical Medicine & International Health"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2018.12.002","article-title":"Snakebite burden in sub-Saharan Africa: Estimates from 41 countries","volume":"159","author":"Halilu","year":"2019","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004568","article-title":"Cost-effectiveness of Antivenoms for snakebite envenoming in 16 countries in West Africa","volume":"10","author":"Hamza","year":"2016","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"10","key":"10.1016\/bs.apcsb.2021.11.004_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005969","article-title":"Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa","volume":"11","author":"Harrison","year":"2017","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"23","key":"10.1016\/bs.apcsb.2021.11.004_bb0390","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.2174\/0929867043363820","article-title":"Dendrotoxins: Structure-activity relationships and effects on potassium ion channels","volume":"11","author":"Harvey","year":"2004","journal-title":"Current Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0395","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1258\/td.2011.110137","article-title":"The impact of snake bite on household economy in Bangladesh","volume":"42","author":"Hasan","year":"2012","journal-title":"Tropical Doctor"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0400","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tox.2009.09.013","article-title":"Antivenom efficacy or effectiveness: The Australian experience","volume":"268","author":"Isbister","year":"2010","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/bs.apcsb.2021.11.004_bb0405","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5694\/j.1326-5377.2008.tb01721.x","article-title":"Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis","volume":"188","author":"Isbister","year":"2008","journal-title":"Medical Journal of Australia"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0410","series-title":"Immunobiology: The immune system in health and disease","article-title":"The structure of a typical antibody molecule","author":"Janeway","year":"2001"},{"issue":"23","key":"10.1016\/bs.apcsb.2021.11.004_bb0415","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1111\/j.1742-4658.2011.08115.x","article-title":"Enzymatic toxins from snake venom: Structural characterization and mechanism of catalysis","volume":"278","author":"Kang","year":"2011","journal-title":"The FEBS Journal"},{"issue":"11","key":"10.1016\/bs.apcsb.2021.11.004_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050218","article-title":"The global burden of snakebite: A literature analysis and modelling based on regional estimates of envenoming and deaths","volume":"5","author":"Kasturiratne","year":"2008","journal-title":"PLoS Medicine"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0425","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.toxicon.2018.07.012","article-title":"Development of an ELISA assay to determine neutralising capacity of horse serum following immunisation with Daboia siamensis venom in Myanmar","volume":"151","author":"Khaing","year":"2018","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0430","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acs.bioconjchem.8b00912","article-title":"Optimization of enzymatic antibody fragmentation for yield, efficiency, and binding affinity","volume":"30","author":"Kinman","year":"2019","journal-title":"Bioconjugate Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0435","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40409-015-0033-8","article-title":"Snakes and snakebite envenoming in northern Tanzania: A neglected tropical health problem","volume":"21","author":"Kipanyula","year":"2015","journal-title":"Journal of Venomous Animals and Toxins Including Tropical Diseases"},{"issue":"8","key":"10.1016\/bs.apcsb.2021.11.004_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8080244","article-title":"A single dose of Viperfav(TM) may be inadequate for Vipera ammodytes Snake bite: A case report and pharmacokinetic evaluation","volume":"8","author":"Kurtovic","year":"2016","journal-title":"Toxins (Basel)"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0445","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1081\/CLT-120021113","article-title":"Snake antivenoms: antivenoms","volume":"41","author":"Lalloo","year":"2003","journal-title":"Journal of Toxicology. Clinical Toxicology"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0450","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1081\/TXR-120019017","article-title":"Merits of sheep antisera for antivenom manufacture","volume":"22","author":"Landon","year":"2003","journal-title":"Journal of Toxicology - Toxin Reviews"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0455","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jprot.2016.02.003","article-title":"Toxicovenomics and antivenom profiling of the eastern green mamba snake (Dendroaspis angusticeps)","volume":"136","author":"Lauridsen","year":"2016","journal-title":"Journal of Proteomics"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0460","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jprot.2016.08.024","article-title":"Exploring the venom of the forest cobra snake: Toxicovenomics and antivenom profiling of Naja melanoleuca","volume":"150","author":"Lauridsen","year":"2017","journal-title":"Journal of Proteomics"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0465","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jprot.2015.02.002","article-title":"Unveiling the nature of black mamba (Dendroaspis polylepis) venom through venomics and antivenom immunoprofiling: Identification of key toxin targets for antivenom development","volume":"119","author":"Laustsen","year":"2015","journal-title":"Journal of Proteomics"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0470","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxicon.2018.03.004","article-title":"Pros and cons of different therapeutic antibody formats for recombinant antivenom development","volume":"146","author":"Laustsen","year":"2018","journal-title":"Toxicon"},{"issue":"10","key":"10.1016\/bs.apcsb.2021.11.004_bb0475","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/toxins10100393","article-title":"Antibody cross-reactivity in antivenom research","volume":"10","author":"Ledsgaard","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0480","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.toxicon.2013.09.010","article-title":"Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms","volume":"76","author":"Leon","year":"2013","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/bs.apcsb.2021.11.004_bb0485","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0041-0101(00)00209-9","article-title":"Comparison between IgG and F(ab')(2) polyvalent antivenoms: Neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions","volume":"39","author":"Leon","year":"2001","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0490","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4269\/ajtmh.1999.61.266","article-title":"Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom","volume":"61","author":"Leon","year":"1999","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb882","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.toxicon.2019.03.020","article-title":"IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy","volume":"163","author":"Leiva","year":"2019","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/bs.apcsb.2021.11.004_bb0495","first-page":"381","article-title":"Immune response towards snake venoms","volume":"10","author":"Le\u00f3n","year":"2011","journal-title":"Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy)(Discontinued)"},{"issue":"10148","key":"10.1016\/bs.apcsb.2021.11.004_bb0500","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(18)31224-8","article-title":"Vulnerability to snakebite envenoming: A global mapping of hotspots","volume":"392","author":"Longbottom","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0505","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.toxicon.2019.09.010","article-title":"Development of a cell-based in vitro assay as a possible alternative for determining bothropic antivenom potency","volume":"170","author":"Lopes-de-Souza","year":"2019","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/bs.apcsb.2021.11.004_bb0510","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1580\/1080-6032(2003)14[220:SSFAOA]2.0.CO;2","article-title":"Serum sickness following administration of antivenin (Crotalidae) polyvalent in 181 cases of presumed rattlesnake envenomation","volume":"14","author":"LoVecchio","year":"2003","journal-title":"Wilderness & Environmental Medicine"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0515","series-title":"Handbook of venoms and toxins of reptiles","first-page":"3","article-title":"The field of reptile toxinology: Snakes, lizards, and their venoms","author":"Mackessy","year":"2009"},{"issue":"5","key":"10.1016\/bs.apcsb.2021.11.004_bb0520","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/icb\/icw110","article-title":"Understanding biological roles of venoms among the Caenophidia: The importance of rear-fanged snakes","volume":"56","author":"Mackessy","year":"2016","journal-title":"Integrative and Comparative Biology"},{"issue":"6512","key":"10.1016\/bs.apcsb.2021.11.004_bb0525","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.292.6512.17","article-title":"Prediction, prevention, and mechanism of early (anaphylactic) antivenom reactions in victims of snake bites","volume":"292","author":"Malasit","year":"1986","journal-title":"British Medical Journal (Clinical Research Ed.)"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0530","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jprot.2013.11.012","article-title":"Proteomic analysis of Moroccan cobra Naja haje legionis venom using tandem mass spectrometry","volume":"96","author":"Malih","year":"2014","journal-title":"Journal of Proteomics"},{"issue":"10","key":"10.1016\/bs.apcsb.2021.11.004_bb0535","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0041-0101(01)00130-1","article-title":"Determination of the neutralizing potency of horse antibothropic and anticrotalic antivenoms in blood samples collected on filter paper","volume":"39","author":"Maria","year":"2001","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0540","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4269\/ajtmh.1997.56.291","article-title":"First clinical experiences with a new ovine fab Echis ocellatus snake bite antivenom in Nigeria: Randomized comparative trial with institute Pasteur serum (Ipser) Africa antivenom","volume":"56","author":"Meyer","year":"1997","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1016\/bs.apcsb.2021.11.004_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001018","article-title":"Snakebite mortality in India: A nationally representative mortality survey","volume":"5","author":"Mohapatra","year":"2011","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0550","doi-asserted-by":"crossref","DOI":"10.1186\/s40409-018-0144-0","article-title":"Antivenom therapy: Efficacy of premedication for the prevention of adverse reactions","volume":"24","author":"Morais","year":"2018","journal-title":"Journal of Venomous Animals and Toxins Including Tropical Diseases"},{"issue":"8","key":"10.1016\/bs.apcsb.2021.11.004_bb0555","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.toxicon.2005.08.006","article-title":"Effect of pepsin digestion on the antivenom activity of equine immunoglobulins","volume":"46","author":"Morais","year":"2005","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0560","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/bab.68","article-title":"A model mechanism for protein precipitation by caprylic acid: Application to plasma purification","volume":"59","author":"Morais","year":"2012","journal-title":"Biotechnology and Applied Biochemistry"},{"issue":"11","key":"10.1016\/bs.apcsb.2021.11.004_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10110474","article-title":"Snake venom peptides: Tools of biodiscovery","volume":"10","author":"Munawar","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0570","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1590\/S1678-91992012000200011","article-title":"Determination of in vivo toxicity and in vitro cytotoxicity of venom from the Cypriot blunt-nosed viper Macrovipera lebetina lebetina and antivenom production","volume":"18","author":"Nalbantsoy","year":"2012","journal-title":"Journal of Venomous Animals and Toxins Including Tropical Diseases"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0575","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4038\/sljm.v27i1.79","article-title":"Pharmacodynamics and pharmacokinetics of snake antivenom","volume":"27","author":"Nikapitiya","year":"2018","journal-title":"Sri Lanka Journal of Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0580","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.toxicon.2011.10.014","article-title":"Optimization by factorial analysis of caprylic acid precipitation of non-immunoglobulins from hyperimmune equine plasma for antivenom preparation","volume":"59","author":"Nudel","year":"2012","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0585","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0041-0101(01)00229-X","article-title":"Toxicity of south American snake venoms measured by an in vitro cell culture assay","volume":"40","author":"Oliveira","year":"2002","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/bs.apcsb.2021.11.004_bb0590","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0041-0101(98)00220-7","article-title":"A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: Correlation between safety and biochemical characteristics of antivenoms","volume":"37","author":"Otero","year":"1999","journal-title":"Toxicon"},{"issue":"12","key":"10.1016\/bs.apcsb.2021.11.004_bb0595","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.trstmh.2006.01.006","article-title":"Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without \u03b2-propiolactone, in the treatment of Bothrops asper bites in Colombia","volume":"100","author":"Otero","year":"2006","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0600","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4269\/ajtmh.1998.58.183","article-title":"A randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia. The regional group on Antivenom therapy research (REGATHER)","volume":"58","author":"Otero-Patino","year":"1998","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0605","first-page":"344","article-title":"Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F (ab') 2] antivenoms","volume":"59","author":"Otero-Pati\u00f1o","year":"2012","journal-title":"Bothrops asper bites in Colombia. Toxicon"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0610","first-page":"20","article-title":"Investigating the cytotoxic effects of the venom proteome of two species of the Viperidae family (Cerastes cerastes and Cryptelytrops purpureomaculatus) from various habitats","volume":"220","author":"Ozverel","year":"2019","journal-title":"Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003419","article-title":"African adders: Partial characterization of snake venoms from three Bitis species of medical importance and their neutralization by experimental equine antivenoms","volume":"9","author":"Paix\u00e3o-Cavalcante","year":"2015","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0620","series-title":"Snake Venoms","first-page":"1","article-title":"Role of lymphatic system on snake venom absorption","author":"Paniagua","year":"2015"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0625","first-page":"74","article-title":"Toxicological screening","volume":"2","author":"Parasuraman","year":"2011","journal-title":"The Journal of Pharmacy and Pharmacology"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0630","doi-asserted-by":"crossref","first-page":"17119","DOI":"10.1038\/s41598-017-17227-y","article-title":"Proteomics and antivenomics of Echis carinatus carinatus venom: Correlation with pharmacological properties and pathophysiology of envenomation","volume":"7","author":"Patra","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2018.08.018","article-title":"Assessment of quality, safety, and pre-clinical toxicity of an equine polyvalent anti-snake venom (pan Africa): Determination of immunological cross-reactivity of antivenom against venom samples of Elapidae and Viperidae snakes of Africa","author":"Patra","year":"2018","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0640","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0041-0101(96)00144-4","article-title":"Immunoreactivity of a new generation of horse F(ab')2 preparations against European viper venoms and the tetanus toxin","volume":"35","author":"Pepin-Covatta","year":"1997","journal-title":"Toxicon"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0645","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jprot.2016.06.018","article-title":"Top-down venomics of the east African green mamba, Dendroaspis angusticeps, and the black mamba, Dendroaspis polylepis, highlight the complexity of their toxin arsenals","volume":"146","author":"Petras","year":"2016","journal-title":"Journal of Proteomics"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0650","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1021\/pr101040f","article-title":"Snake venomics of African spitting cobras: Toxin composition and assessment of congeneric cross-reactivity of the pan-African EchiTAb-plus-ICP antivenom by antivenomics and neutralization approaches","volume":"10","author":"Petras","year":"2011","journal-title":"Journal of Proteome Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0655","first-page":"132","article-title":"The action of proteolytic enzymes on the antitoxins and proteins in immune sera: I. true digestion of the proteins","volume":"20","author":"Pope","year":"1939","journal-title":"British Journal of Experimental Pathology"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0660","first-page":"201","article-title":"The action of proteolytic enzymes on the antitoxins and proteins in immune sera: II. Heat denaturation after partial enzyme action","volume":"20","author":"Pope","year":"1939","journal-title":"British Journal of Experimental Pathology"},{"issue":"6","key":"10.1016\/bs.apcsb.2021.11.004_bb0665","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007551","article-title":"Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-Centre, multi-antivenom clinical trial","volume":"13","author":"Potet","year":"2019","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0670","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3389\/fimmu.2019.01598","article-title":"History of envenoming therapy and current perspectives","volume":"10","author":"Pucca","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"10","key":"10.1016\/bs.apcsb.2021.11.004_bb0675","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000860","article-title":"Annual incidence of snake bite in rural Bangladesh","volume":"4","author":"Rahman","year":"2010","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0680","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1038\/s41598-018-27794-3","article-title":"An in vitro potency assay using nicotinic acetylcholine receptor binding works well with antivenoms against Bungarus candidus and Naja naja","volume":"8","author":"Ratanabanangkoon","year":"2018","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0685","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1038\/s41598-017-08962-3","article-title":"A novel in vitro potency assay of antisera against Thai Naja kaouthia based on nicotinic acetylcholine receptor binding","volume":"7","author":"Ratanabanangkoon","year":"2017","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/bs.apcsb.2021.11.004_bb0690","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.toxicon.2006.07.004","article-title":"A new ELISA for determination of potency in snake antivenoms","volume":"48","author":"Rial","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0695","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2017.08.020","article-title":"Differential procoagulant effects of saw-scaled viper (Serpentes: Viperidae: Echis) snake venoms on human plasma and the narrow taxonomic ranges of antivenom efficacies","volume":"280","author":"Rogalski","year":"2017","journal-title":"Toxicology Letters"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0700","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxicon.2013.03.013","article-title":"Role of the animal model on the pharmacokinetics of equine-derived antivenoms","volume":"70","author":"Rojas","year":"2013","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/bs.apcsb.2021.11.004_bb0705","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1067\/mem.2002.123698","article-title":"Initial postmarketing experience with crotalidae polyvalent immune fab for treatment of rattlesnake envenomation","volume":"39","author":"Ruha","year":"2002","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0710","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.toxicon.2015.10.012","article-title":"Clinical features of serum sickness after Australian snake antivenom","volume":"108","author":"Ryan","year":"2015","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0715","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/15563650.2015.1101771","article-title":"Incidence of serum sickness after the administration of Australian snake antivenom (ASP-22)","volume":"54","author":"Ryan","year":"2016","journal-title":"Clinical Toxicology"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijvsm.2016.09.001","article-title":"The new algorithm for calculation of median lethal dose (LD50) and effective dose fifty (ED50) of Micrarus fulvius venom and anti-venom in mice","volume":"4","author":"Saganuwan","year":"2016","journal-title":"International Journal of Veterinary Science and Medicine"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0725","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/mem.2001.113135","article-title":"Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies","volume":"37","author":"Seifert","year":"2001","journal-title":"Annals of Emergency Medicine"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0730","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0041-0101(03)00125-9","article-title":"Animal experimentation in snake venom research and in vitro alternatives","volume":"42","author":"Sells","year":"2003","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/bs.apcsb.2021.11.004_bb0735","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0041-0101(98)00004-X","article-title":"A humane alternative to the measurement of the lethal effects (LD50) of non-neurotoxic venoms using hens' eggs","volume":"36","author":"Sells","year":"1998","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/bs.apcsb.2021.11.004_bb0740","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0041-0101(00)00191-4","article-title":"An in vivo but insensate model for the evaluation of antivenoms (ED50) using fertile hens' eggs","volume":"39","author":"Sells","year":"2001","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0745","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/BST20190739","article-title":"Current research into snake antivenoms, their mechanisms of action and applications","volume":"48","author":"Silva","year":"2020","journal-title":"Biochemical Society Transactions"},{"issue":"8","key":"10.1016\/bs.apcsb.2021.11.004_bb0750","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0041-0101(92)90384-H","article-title":"An affinity purified ovine antivenom for the treatment of Vipera berus envenoming","volume":"30","author":"Smith","year":"1992","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/bs.apcsb.2021.11.004_bb0755","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4269\/ajtmh.13-0591","article-title":"Anticomplementary activity of horse IgG and F (ab') 2 antivenoms","volume":"90","author":"Squaiella-Baptistao","year":"2014","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0760","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.toxicon.2018.05.008","article-title":"The history of antivenoms development: Beyond Calmette and vital Brazil","volume":"150","author":"Squaiella-Baptistao","year":"2018","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/bs.apcsb.2021.11.004_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002326","article-title":"Immune response to snake envenoming and treatment with antivenom; complement activation, cytokine production and mast cell degranulation","volume":"7","author":"Stone","year":"2013","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"4","key":"10.1016\/bs.apcsb.2021.11.004_bb0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006427","article-title":"In vitro assessment of cytotoxic activities of Lachesis muta muta snake venom","volume":"12","author":"Stransky","year":"2018","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"11","key":"10.1016\/bs.apcsb.2021.11.004_bb0775","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3390\/toxins5112172","article-title":"Three-fingered RAVERs: Rapid accumulation of variations in exposed residues of snake venom toxins","volume":"5","author":"Sunagar","year":"2013","journal-title":"Toxins (Basel)"},{"issue":"9","key":"10.1016\/bs.apcsb.2021.11.004_bb0780","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9090290","article-title":"A review and database of Snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins (Basel)"},{"issue":"8039","key":"10.1016\/bs.apcsb.2021.11.004_bb884","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(77)92502-8","article-title":"Micro-ELISA for detecting and assaying snake venom and venom-antibody","volume":"310","author":"Theakston","year":"1977","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/bs.apcsb.2021.11.004_bb0785","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0041-0101(79)90284-8","article-title":"Enzyme-linked immunosorbent assay (ELISA) in assessing antivenom potency","volume":"17","author":"Theakston","year":"1979","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/bs.apcsb.2021.11.004_bb0790","first-page":"949","article-title":"Development of simple standard assay procedures for the characterization of snake venoms","volume":"61","author":"Theakston","year":"1983","journal-title":"Bulletin of the World Health Organization"},{"issue":"5","key":"10.1016\/bs.apcsb.2021.11.004_bb0795","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0041-0101(02)00393-8","article-title":"Report of a WHO workshop on the standardization and control of antivenoms","volume":"41","author":"Theakston","year":"2003","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0800","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/vetsci8020014","article-title":"Diagnosis and treatment of Snake envenomation in dogs in Queensland","volume":"8","author":"Valenza","year":"2021","journal-title":"Australia. Veterinary sciences"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb881","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.crvi.2006.10.001","article-title":"The phylogeny and classification of caenophidian snakes inferred from seven nuclear protein-coding genes","volume":"330","author":"Vidal","year":"2007","journal-title":"Comptes Rendus Biologies"},{"issue":"5","key":"10.1016\/bs.apcsb.2021.11.004_bb0805","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.trstmh.2007.11.006","article-title":"Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: The importance of quality surveillance","volume":"102","author":"Visser","year":"2008","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0810","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.gene.2006.03.008","article-title":"Venom gland EST analysis of the saw-scaled viper, Echis ocellatus, reveals novel alpha9beta1 integrin-binding motifs in venom metalloproteinases and a new group of putative toxins, renin-like aspartic proteases","volume":"377","author":"Wagstaff","year":"2006","journal-title":"Gene"},{"issue":"6","key":"10.1016\/bs.apcsb.2021.11.004_bb0815","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jprot.2008.10.003","article-title":"Combined snake venomics and venom gland transcriptomic analysis of the ocellated carpet viper","volume":"71","author":"Wagstaff","year":"2009","journal-title":"Echis ocellatus. J Proteomics"},{"issue":"2","key":"10.1016\/bs.apcsb.2021.11.004_bb0820","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dci.2015.07.017","article-title":"Equine immunoglobulins and organization of immunoglobulin genes","volume":"53","author":"Walther","year":"2015","journal-title":"Developmental and Comparative Immunology"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0825","doi-asserted-by":"crossref","unstructured":"Warrell, D. A. 2008. Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product--'what's in a name?\u2018. Transactions of the Royal Society of Tropical Medicine and Hygiene 102(5), 397\u2013399. https:\/\/doi.org\/10.1016\/j.trstmh.2007.12.005","DOI":"10.1016\/j.trstmh.2007.12.005"},{"issue":"9","key":"10.1016\/bs.apcsb.2021.11.004_bb0830","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/qjmed\/hcp075","article-title":"Commissioned article: Management of exotic snakebites","volume":"102","author":"Warrell","year":"2009","journal-title":"QJM: An International Journal of Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0835","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0035-9203(76)90012-2","article-title":"Neurotoxic effects of bites by the Egyptian cobra (Naja haje) in Nigeria","volume":"70","author":"Warrell","year":"1976","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0840","first-page":"33","article-title":"Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria","volume":"46","author":"Warrell","year":"1977","journal-title":"QJM: An International Journal of Medicine"},{"issue":"5942","key":"10.1016\/bs.apcsb.2021.11.004_bb0845","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/bmj.4.5942.437","article-title":"Bites by the saw-scaled or carpet viper (Echis carinatus): Trial of two specific antivenoms","volume":"4","author":"Warrell","year":"1974","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1016\/bs.apcsb.2021.11.004_bb0850","first-page":"1","article-title":"Necrosis, haemorrhage and complement depletion following bites by the spitting cobra (Naja nigricollis)","volume":"45","author":"Warrell","year":"1976","journal-title":"QJM: An International Journal of Medicine"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0855","series-title":"Expert committee on biological standardization World Health Organization","author":"WHO","year":"2016"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0860","series-title":"WHO guidelines for the production","author":"WHO","year":"2016"},{"key":"10.1016\/bs.apcsb.2021.11.004_bb0865","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2018.05.001","article-title":"Clinical studies of the effectiveness and safety of antivenoms","volume":"150","author":"Williams","year":"2018","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/bs.apcsb.2021.11.004_bb0870","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/toxins11060363","article-title":"The urgent need to develop novel strategies for the diagnosis and treatment of snakebites","volume":"11","author":"Williams","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"5","key":"10.1016\/bs.apcsb.2021.11.004_bb0875","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1179\/136485910X12743554760306","article-title":"Management of snakebites by the staff of a rural clinic: The impact of providing free antivenom in a nurse-led clinic in Meserani, Tanzania","volume":"104","author":"Yates","year":"2010","journal-title":"Annals of Tropical Medicine and Parasitology"},{"issue":"1\u20133","key":"10.1016\/bs.apcsb.2021.11.004_bb0880","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-5793(03)00693-8","article-title":"Adaptive evolution in the snake venom Kunitz\/BPTI protein family","volume":"547","author":"Zupunski","year":"2003","journal-title":"FEBS Letters"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162321000857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162321000857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T07:24:22Z","timestamp":1756193062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162321000857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323992275"],"references-count":178,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2021.11.004","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}